Raydiax, a Magdeburg, Germany based startup developing an image assistance system based on the principles of computed tomography for use in minimally invasive cancer treatments, raised €3.5m in funding.
A seed round of €2.4m was led by HTGF and bmp Ventures with IBG funds. In addition, Raydiax will receive €1.1m in funding through a top-up of an “EXIST: transfer of research” grant from the German Federal Ministry for Economic Affairs and Climate Action (BMWK).
The company intends to use the funds to advance the development of the preclinical prototype and prepare for market entry in Europe and the USA.
Lesd by Dr. Thomas Hoffmann, CEO and co-founder, Raydiax is a spin-off of the STIMULATE research campus/ Otto-von-Guericke-University Magdeburg that is advancing an image-assistance system, TACT, to provide assistance with therapy planning, execution and monitoring. The system is characterized by a minimized use of X-rays, resulting in patient-friendly care and safer work conditions for clinical staff.
FinSMEs
27/10/2023